Lorenzo Hess

491 total citations
16 papers, 357 citations indexed

About

Lorenzo Hess is a scholar working on Surgery, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lorenzo Hess has authored 16 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Economics and Econometrics and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lorenzo Hess's work include Lipoproteins and Cardiovascular Health (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Lorenzo Hess is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Lorenzo Hess collaborates with scholars based in Switzerland, United States and Australia. Lorenzo Hess's co-authors include Raymond G. Schlienger, Stephan Kr henb hl, Antoinette Péchère-Bertschi, Paolo Ferrari, Franco Muggli, Michel Burnier, Lydia Tchambaz, Sabin S Egger, Reto Brignoli and W. Vetter and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of Hypertension and Drug Safety.

In The Last Decade

Lorenzo Hess

16 papers receiving 341 citations

Peers

Countries citing papers authored by Lorenzo Hess

Since Specialization

Citations

This map shows the geographic impact of Lorenzo Hess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenzo Hess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenzo Hess more than expected).

Fields of papers citing papers by Lorenzo Hess

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenzo Hess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenzo Hess. The network helps show where Lorenzo Hess may publish in the future.

Co-authorship network of co-authors of Lorenzo Hess

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenzo Hess. A scholar is included among the top collaborators of Lorenzo Hess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenzo Hess. Lorenzo Hess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Evaluation of Treatment Effect in Underrepresented Population in Cancer Trials: Discussion with International Regulators 2022 ·Statistics in Biopharmaceutical Research ·Rajeshwari Sridhara, (unknown), Qing Jiang, (unknown), Jie Chen, Nancy A Dreyer, Lola A. Fashoyin‐Aje, Elizabeth Garrett‐Mayer, Nicole Gormley, Thomas Gwise, Lorenzo Hess, Sumithra J. Mandrekar, Francesco Pignatti, Khadija Rantell, (unknown), (unknown), Harpreet Singh, Craig Tendler, Marc R. Theoret, Richard Pazdur	1
2	Use of Nonconcurrent Common Control in Master Protocols in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion 2021 ·Statistics in Biopharmaceutical Research ·Rajeshwari Sridhara, (unknown), Qi Jiang, Richard Pazdur, Martin Posch, Scott Berry, Marc R. Theoret, Yuan Li Shen, Thomas Gwise, Lorenzo Hess, (unknown), Khadija Rantell, Kit C. B. Roes, Richard H. Simon, Mary W. Redman, Yuan Ji, (unknown)	16
3	Type I Error Considerations in Master Protocols With Common Control in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion 2021 ·Statistics in Biopharmaceutical Research ·Rajeshwari Sridhara, (unknown), Qi Jiang, Richard Pazdur, Martin Posch, Mary W. Redman, Yevgen Tymofyeyev, Xiaoyun Li, Marc R. Theoret, Yuan Li Shen, Thomas Gwise, Lorenzo Hess, Michael Coory, (unknown), (unknown), Kit C. B. Roes, Filip Josephson, Scott Berry, Richard H. Simon, Bruce Binkowitz	8
4	Gamma-Linolenic Acid Levels Correlate with Clinical Efficacy of Evening Primrose Oil in Patients with Atopic Dermatitis 2014 ·Advances in Therapy ·Dagmar Simon, Peter Eng, Siegfried Borelli, (unknown), Christian Zimmermann, Catherine Zahner, Jürgen Drewe, Lorenzo Hess, Giovanni Ferrari, Stephan Lautenschlager, Brunello Wüthrich, Peter Schmid‐Grendelmeier	39
5	Gamma-Linolenic Acid Levels Correlate with Clinical Efficacy of Evening Primrose Oil in Patients with Atopic Dermatitis Dagmar SimonPeter A. EngSiegfried BorelliRoland KagiChristian Zimmermann • Catherine ZahnerJurgen DreweLorenzo HessGiovanni Ferrari • Stephan LautenschlagerBrunello WuthrichPeter Schmid-Grendelmeier 2014 ·Dagmar Simon, (unknown), (unknown), (unknown), Jürgen Drewe, Lorenzo Hess	2
6	The effects of the “physical BEMER^® vascular therapy”, a method for the physical stimulation of the vasomotion of precapillary microvessels in case of impaired microcirculation, on sleep, pain and quality of life of patients with different clinical pictures on the basis of three scientifically validated scales 2013 ·Journal of Complementary and Integrative Medicine ·(unknown), Lorenzo Hess, (unknown)	9
7	Dose-Dependent Effects of theCimicifuga racemosaExtract Ze 450 in the Treatment of Climacteric Complaints: A Randomized, Placebo-Controlled Study 2012 ·Evidence-based Complementary and Alternative Medicine ·Ruediger Schellenberg, Reinhard Saller, Lorenzo Hess, Jörg Melzer, Christian Zimmermann, Jürgen Drewe, Catherine Zahner	17
8	Petasol butenoate complex (Ze 339) relieves allergic rhinitis–induced nasal obstruction more effectively than desloratadine 2011 ·Journal of Allergy and Clinical Immunology ·(unknown), Mohamed H. Shamji, Martin Wagenmann, (unknown), Kathrin Scheckenbach, Jens Greve, Thomas Klenzner, Lorenzo Hess, Sabine Nebel, Christian Zimmermann, Catherine Zahner, Carsten B. Schmidt‐Weber, Adam Chaker	22
9	Persistent dyslipidemia in statin-treated patients: The focus on comprehensive lipid management survey in Swiss patients 2011 ·Swiss Medical Weekly ·Lorenzo Hess, (unknown)	5
10	Age-Related Differences in the Prevalence of Potential Drug-Drug Interactions in Ambulatory Dyslipidaemic Patients Treated with Statins 2007 ·Drugs & Aging ·Sabin S Egger, (unknown), Lorenzo Hess, Raymond G. Schlienger, Stephan Kr henb hl	56
11	Prävalenz potentieller Arzneimittelinteraktionen bei ambulanten Patienten unter Statin-Therapie 2006 ·Praxis ·(unknown), (unknown), (unknown), Lorenzo Hess, (unknown), (unknown)	2
12	Prevalence of Potentially Severe Drug-Drug Interactions in Ambulatory Patients with Dyslipidaemia Receiving HMG-CoA Reductase Inhibitor Therapy 2005 ·Drug Safety ·(unknown), Lydia Tchambaz, (unknown), Lorenzo Hess, Raymond G. Schlienger, Stephan Kr henb hl	64
13	Swiss Hypertension and Risk Factor Program (SHARP): Cardiovascular risk factors management in patients with type 2 diabetes in Switzerland 2005 ·Blood Pressure ·Antoinette Péchère-Bertschi, P Greminger, Lorenzo Hess, Jacques Philippé, Paolo Ferrari	32
14	Reasons for not intensifying antihypertensive treatment (RIAT) 2004 ·Journal of Hypertension ·Paolo Ferrari, Lorenzo Hess, Antoinette Péchère-Bertschi, Franco Muggli, Michel Burnier	58
15	Influence of self-measurement of blood pressure on the responder rate in hypertensive patients treated with losartan: results of the SVATCH Study 2000 ·Journal of Human Hypertension ·W. Vetter, Lorenzo Hess, Reto Brignoli	23
16	Leuprolide acetate depot for the treatment of uterine leiomyomas. Changes in bone density, uterine volume and uterine vascular resistive index. 1994 ·PubMed ·Michel E. Rivlin, (unknown), Lorenzo Hess, (unknown), G. Rodney Meeks	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact